Xspray Pharma AB (publ) (XSPRAY) Plans SEK 90M Rights Issue, Up to SEK 162M Total

Xspray Pharma AB (publ) (XSPRAY) Plans SEK 90M Rights Issue, Up to SEK 162M Total

1 min read

Xspray resolved on a rights issue of approximately SEK 90M, with an over-allotment issue of up to approximately SEK 72M. Subscription undertakings and intentions total approximately SEK 104M; proceeds are intended to fund preparations for anticipated product approvals and launches.

Material Details

| # | Detail | AI Analyst View |

|---|---|---|

| 1 | Rights issue: approx. SEK 90M at SEK 9.50/share | The issue provides financing but creates dilution; investors who do not participate face approximately 17% dilution if fully subscribed. |

| 2 | Over-allotment: up to approx. SEK 72M | If fully exercised, combined gross proceeds could reach approximately SEK 162M and dilution approximately 26%. |

| 3 | Commitments and intentions: approx. SEK 104M | Indicated demand is about 116% of the rights issue, though subscription intentions are not secured by bank guarantees or similar arrangements. |

| 4 | Proceeds expected to cover needs to anticipated approvals | Funding runway is tied to anticipated approvals; if launches are delayed, the company estimates coverage of approximately 12 months. |

| 5 | F...